These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24919464)

  • 1. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
    Yang J; Zhu L; Cai Y; Suo J; Jin J
    Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer.
    Jiang J; Jin MS; Kong F; Cao D; Ma HX; Jia Z; Wang YP; Suo J; Cao X
    PLoS One; 2013; 8(12):e81799. PubMed ID: 24339967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma.
    Cao L; Zhu L; Yang J; Su J; Ni J; Du Y; Liu D; Wang Y; Wang F; Jin J; Cai Y
    Int J Oncol; 2014 Apr; 44(4):1207-14. PubMed ID: 24452485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.
    Kim SJ; Hwang JA; Ro JY; Lee YS; Chun KH
    Oncotarget; 2013 Sep; 4(9):1461-71. PubMed ID: 23985992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
    Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
    Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.
    Wang Z; Yin N; Zhang Z; Zhang Y; Zhang G; Chen W
    Immunol Invest; 2017 Feb; 46(2):134-148. PubMed ID: 27911104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
    Ling Y; Shi X; Wang Y; Ling X; Li Q
    Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
    Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
    Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
    Xia R; Wang F; Gao T; Wen W; Lu B; Zhu Y; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):740-3. PubMed ID: 25001941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
    Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
    Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological significance in benign and malignant lesions of stomach].
    Zhou JP; Yang ZL; Liu DC; Zhou JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):297-300. PubMed ID: 19434543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tumoral expression of galectin-9 in gastric cancer.
    Choi SI; Seo KW; Kook MC; Kim CG; Kim YW; Cho SJ
    Turk J Gastroenterol; 2017 May; 28(3):166-170. PubMed ID: 28492371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis].
    Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):105-8. PubMed ID: 16468655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
    Wei B; Huang QY; Huang SR; Mai W; Zhong XG
    Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
    Sun G; Zhao G; Lu Y; Wang Y; Yang C
    Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.